361 Capital’s Natus Medical Inc NTUS Stock Holding History

361 Capital’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-54,179	Closed	-$2.07M	–	361
2017 Q4	$2.07M	Buy	+54,179	New	+$2.16M	0.51%	101

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

VCM

Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

361 Capital's NTUS Position: Q1 2018 in Review

361 Capital sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 54,179 shares — an estimated $2.07M sold.

361 Capital first reported a position in NTUS in Q4 2017 and held it in 1 quarter. The position peaked at $2.07M in Q4 2017. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

361 Capital reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
361 Capital sold 54,179 Natus Medical Inc shares in Q1 2018, an estimated $2.07M.
361 Capital first reported a position in Natus Medical Inc in Q4 2017 and held it in 1 quarter.
361 Capital's Natus Medical Inc position peaked at $2.07M in Q4 2017.
184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on 361 Capital's 13F filing for Q1 2018, filed 15 May 2018.